Evidence map›Paper›PMID 30523152›Full record

Trial reportThe Journal of biological chemistry2019

Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders.

Kevin V Hackshaw, Didem P Aykas, Gregory T Sigurdson, Marcal Plans, Francesca Madiai, Lianbo Yu, Charles A T Buffington, M Mónica Giusti, Luis Rodriguez-Saona

Erratum issuedOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Urinary metabolites and fatigue in a population-based metabolomics study: an exploratory analysis.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  4. Development of a Novel 11-Gene Signature Related to Immune Subtypes for FibromyalgiaEndocrine, metabolic & immune disorders drug targets · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Novel Approaches in Molecular Imaging and Neuroimaging of Fibromyalgia.International journal of molecular sciences · 2022
    Review
  17. The Interplay between Chronic Pain, Opioids, and the Immune System.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Kevin V HackshawFrom the Department of Internal Medicine, Division of Rheumatology and Immunology, Kevin.Hackshaw@osumc.edu.ORCID 0000-0002-9780-7171
Didem P Aykasthe Department of Food Science and Technology, and.
Gregory T Sigurdsonthe Department of Food Science and Technology, and.
Marcal Plansthe Department of Food Science and Technology, and.
Francesca MadiaiFrom the Department of Internal Medicine, Division of Rheumatology and Immunology.
Lianbo Yuthe Center of Biostatistics and Bioinformatics, Ohio State University, Columbus, Ohio 43210 and.
Charles A T Buffingtonthe Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California 95616.
M Mónica Giustithe Department of Food Science and Technology, and.
Luis Rodriguez-Saonathe Department of Food Science and Technology, and.
Institute of Food Science and Technology · CNCenter for Rheumatology · USThe Ohio State University · USUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis and treatment of fibromyalgia (FM) remains a challenge owing to the lack of reliable biomarkers. Our objective was to develop a rapid biomarker-based method for diagnosing FM by using vibrational spectroscopy to differentiate patients with FM from those with rheumatoid arthritis (RA), osteoarthritis (OA), or systemic lupus erythematosus (SLE) and to identify metabolites associated with these differences. Blood samples were collected from patients with a diagnosis of FM (

Indexed as

AdultBiomarkersChromatography, High Pressure LiquidFemaleFibromyalgiaHumansMaleMiddle AgedPainPain MeasurementSpectrophotometry, InfraredSurveys and QuestionnairesBiomarkersbiomarkerbloodfibromyalgiafingerprintinghigh-performance liquid chromatography (HPLC)infrared spectroscopy (IR spectroscopy)mass spectrometry (MS)painRaman spectroscopy

Identifiers

PMID30523152
PMCPMC6378985
OpenAlexW2904499668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.